Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
12,98 NOK | +0,62% | +0,15% | -39,35% |
Omzet 2024 * | 157 mln. 14,24 mln. 13,31 mln. | Omzet 2025 * | 190 mln. 17,22 mln. 16,1 mln. | Marktkapitalisatie | 4,24 mld. 384 mln. 359 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -613 mln. -55,6 mln. -51,97 mln. | Nettowinst (verlies) 2025 * | -735 mln. -66,67 mln. -62,31 mln. | EV/omzet 2024 * | 19 x |
Nettoliquiditeiten 2024 * | 1,25 mld. 114 mln. 106 mln. | Nettoliquiditeiten 2025 * | 1,01 mld. 91,53 mln. 85,55 mln. | EV/omzet 2025 * | 17 x |
K/w-verhouding 2024 * |
-6,97
x | K/w-verhouding 2025 * |
-6,25
x | Werknemers | 172 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 55% |
Recentste transcriptie over Nykode Therapeutics
1 dag | +0,62% | ||
1 week | +0,15% | ||
Lopende maand | -13,41% | ||
1 maand | -14,83% | ||
3 maanden | -31,76% | ||
6 maanden | -22,92% | ||
Lopend jaar | -39,35% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 47 | 01-01-07 | |
Michael Engsig
CEO | Chief Executive Officer | - | 01-03-07 |
Harald Gurvin
DFI | Director of Finance/CFO | 49 | 03-05-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bernd Seizinger
BRD | Director/Board Member | 67 | - |
Director/Board Member | 64 | - | |
Director/Board Member | - | - |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 773 M€ | -.--% | - | |
0.00% | 10 M€ | -3,35% | - | |
0.00% | 152 M€ | -3,56% | - | |
0.00% | 26 M€ | -4,26% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 12,98 | +0,62% | 639 229 |
25-04-24 | 12,9 | -3,01% | 600 010 |
24-04-24 | 13,3 | -0,82% | 507 883 |
23-04-24 | 13,41 | +1,90% | 425 178 |
22-04-24 | 13,16 | +1,54% | 538 941 |
Real Time Oslo Bors, 26 april 2024 om 16:45 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-39,35% | 384 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |